Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Silvestris

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Clinical and Experimental Immunology|September 18, 2008
Overexpression of interleukin-12 and T helper 1 predominance in lupus nephritisM Tucci, L Lombardi, H B Richards, et al.
International Journal of Clinical & Laboratory Research|January 1, 1997
IgG M-components in active myeloma patients induce a down-regulation of natural killer cell activityM A Frassanito, F Silvestris, P Cafforio, et al.
Journal of Autoimmunity|August 1, 1989
Studies of anti-F(ab')2 antibodies and VH region distribution among SLE kindredsF Silvestris, R A Searles, J D Capra, et al.
The Journal of Laboratory and Clinical Medicine|September 15, 1998
Urinary loss of immunoglobulin G anti-F(ab)2 and anti-DNA antibody in systemic lupus erythematosus nephritisR C Williams, C C Malone, R T Miller, et al.
European Journal of Clinical Investigation|December 3, 1999
Nef protein induces differential effects in CD8+ cells from HIV-1-infected patientsF Silvestris, G Camarda, A Del Prete, et al.
Clinical and Experimental Rheumatology|January 1, 1997
Benign monoclonal gammopathy with IgG anti-DNA, anti-Sm and anti-F(ab')2 activityR C Williams, C C Malone, F Silvestris, et al.
Molecular Medicine (Cambridge, Mass.)|September 6, 2000
VEINCTR-N, an immunogenic epitope of Fas (CD95/Apo-I), and soluble Fas enhance T-cell apoptosis in vitro. II. Functional analysis and possible implications in HIV-1 diseaseF Silvestris, P Cafforio, M Tucci, et al.
Arthritis and Rheumatism|December 1, 1984
Studies of anti-F(ab')2 antibodies and possible immunologic control mechanisms in systemic lupus erythematosusF Silvestris, A D Bankhurst, R P Searles, et al.
Clinical Immunology and Immunopathology|November 1, 1994
Distribution and antigenic analysis of circulating F(ab')2-reactive IgG in patients with HIV-1 infectionF Silvestris, M Di Loreto, A Romito, et al.
Prostaglandins, Leukotrienes, and Medicine|September 1, 1982
In vitro modulation of cell-mediated immunity by prostaglandin E2. I. Enhancing-inhibitory effects on antibody-dependent cellular cytotoxicityS Antonaci, E Jirillo, F Silvestris, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Clinical and Experimental Immunology|September 18, 2008
Overexpression of interleukin-12 and T helper 1 predominance in lupus nephritisM Tucci, L Lombardi, H B Richards, et al.
International Journal of Clinical & Laboratory Research|January 1, 1997
IgG M-components in active myeloma patients induce a down-regulation of natural killer cell activityM A Frassanito, F Silvestris, P Cafforio, et al.
Journal of Autoimmunity|August 1, 1989
Studies of anti-F(ab')2 antibodies and VH region distribution among SLE kindredsF Silvestris, R A Searles, J D Capra, et al.
The Journal of Laboratory and Clinical Medicine|September 15, 1998
Urinary loss of immunoglobulin G anti-F(ab)2 and anti-DNA antibody in systemic lupus erythematosus nephritisR C Williams, C C Malone, R T Miller, et al.
European Journal of Clinical Investigation|December 3, 1999
Nef protein induces differential effects in CD8+ cells from HIV-1-infected patientsF Silvestris, G Camarda, A Del Prete, et al.
Clinical and Experimental Rheumatology|January 1, 1997
Benign monoclonal gammopathy with IgG anti-DNA, anti-Sm and anti-F(ab')2 activityR C Williams, C C Malone, F Silvestris, et al.
Molecular Medicine (Cambridge, Mass.)|September 6, 2000
VEINCTR-N, an immunogenic epitope of Fas (CD95/Apo-I), and soluble Fas enhance T-cell apoptosis in vitro. II. Functional analysis and possible implications in HIV-1 diseaseF Silvestris, P Cafforio, M Tucci, et al.
Arthritis and Rheumatism|December 1, 1984
Studies of anti-F(ab')2 antibodies and possible immunologic control mechanisms in systemic lupus erythematosusF Silvestris, A D Bankhurst, R P Searles, et al.
Clinical Immunology and Immunopathology|November 1, 1994
Distribution and antigenic analysis of circulating F(ab')2-reactive IgG in patients with HIV-1 infectionF Silvestris, M Di Loreto, A Romito, et al.
Prostaglandins, Leukotrienes, and Medicine|September 1, 1982
In vitro modulation of cell-mediated immunity by prostaglandin E2. I. Enhancing-inhibitory effects on antibody-dependent cellular cytotoxicityS Antonaci, E Jirillo, F Silvestris, et al.
Pageof 8